{"id":"W4379283040","doi":"10.1200/jco.2023.41.16_suppl.2519","title":"A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Chimeric antigen receptor; Breast cancer; Immunotherapy; Cancer; Cancer research; Leukapheresis; T cell; Oncology; Internal medicine; Immunology; Immune system; Stem cell; CD34","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001536695,0.001285638,0.001155296,0.0003886092,0.0003462592,0.0009453826,0.0009480409,0.001529809,0.005049645],"category_scores_gemma":[0.0007239832,0.0004372271,0.0008183378,0.0004033604,0.001006106,0.0008167229,0.000313262,0.002951755,0.001491833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008488141,"about_ca_system_score_gemma":0.001699138,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007370903,"about_ca_topic_score_gemma":0.001261951,"domain_scores_codex":[0.9996132,0.0001844142,0.0000181128,0.00006257399,0.00003716676,0.00008446438],"domain_scores_gemma":[0.9993845,0.0000956273,0.000115356,0.00007016636,0.00003503007,0.0002993149],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7491771,0.09143061,0.004963918,0.0009391754,0.000941753,0.0007228098,0.0002491459,0.002865622,0.05927449,0.0006480514,0.007842395,0.08094499],"study_design_scores_gemma":[0.5624704,0.4235146,0.004009319,0.00003162158,0.0002483158,0.0004491113,0.00004184096,0.001163075,0.004761019,0.0002855812,0.003008534,0.00001659874],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9857383,0.002042997,0.0007760121,0.0006404553,0.0002120651,0.004914061,0.002015689,0.0001606353,0.00349979],"genre_scores_gemma":[0.9827219,0.001302997,0.001552868,0.001239541,0.0001989849,0.004216225,0.004473663,0.00003991892,0.004253892],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005049645,"threshold_uncertainty_score":0.01689273,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2245488059784758,"score_gpt":0.54106261968792,"score_spread":0.3165138137094442,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}